Craniopharyngioma recurrence and growth hormone therapy

Lancet. 1988 Mar 19;1(8586):642. doi: 10.1016/s0140-6736(88)91434-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Craniopharyngioma / therapy*
  • Female
  • Follow-Up Studies
  • Growth Disorders / drug therapy
  • Growth Substances / adverse effects*
  • Humans
  • Infant
  • Male
  • Neoplasm Recurrence, Local / chemically induced*
  • Pituitary Neoplasms / therapy*

Substances

  • Growth Substances